US Retinal Market Quarterly Updates
Our US Retinal Market Quarterly Updates are designed to keep you up to date with data gathered four times per year on the practice of retinal medicine, both pharmaceutical and surgical. We began this survey process in 2008. These updates are designed to improve your decision-making process with accurate and timely information on a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, and the identification of significant trends in the marketplace for retinal pharmaceuticals and devices.
Our updates include trend analysis based on comparisons with information gathered in previous years. All information is presented in color charts and tables with concise narratives for enhanced clarity and context.
We measure and analyze the key metrics of the US retina treatments market, including the following topics:
Use of Lucentis, Avastin, and Eylea
Photocoagulation Volume and Photocoagulators Used
Use of Jetrea
Vitrectomy Volume and Location
Disposable Procedure Packs
Reusable and Disposable Instruments
We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year. The survey has been developed in conjunction with retina specialists and industry manufacturers.
Our US Retina Quarterly Market Updates are published each quarter. We have been conducting surveys of ophthalmologists in various subspecialties for 12 years, and our analyses of survey data are used by hundreds of ophthalmological practices and businesses in the ophthalmic industry. Each update can be purchased separately for $3,000, or an annual subscription is available for $10,750.
*Note: The PDFs are not downloadable: PDF copies of reports are manually prepared and emailed to the account listed on the order within 24 hours. Please call our office for immediate assistance or to discuss purchasing additional copies of a report at (314) 835-0600.
VIEW THE TABLE OF CONTENTS FOR THIS REPORT